The U.S. home healthcare market size was exhibited at USD 143.95 billion in 2023 and is projected to hit around USD 296.41 billion by 2033, growing at a CAGR of 7.49% during the forecast period 2024 to 2033.
| Report Coverage | Details |
| Market Size in 2024 | USD 154.73 Billion |
| Market Size by 2033 | USD 296.41 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 7.49% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Component |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | U.S. |
| Key Companies Profiled | McKesson Medical-Surgical, Inc.; NxStage Medical (Fresenius Medical Care); Medline Industries Inc.; Medtronic plc; 3M Healthcare; Baxter International Inc.; B. Braun Melsungen AG; F. Hoffman-La Roche AG; Becton, Dickinson and Company; Kindred Healthcare, LLC; Brookdale Senior Living Inc.; Sunrise Senior Living, LLC; Genesis Healthcare, Inc.; Capital Senior Living Corporation (Sonida Senior Living); Diversicare Healthcare Services, Inc.; Senior Care Center; Atria Senior Living, Inc.; Amedisys, Inc.; Home Instead, Inc. |
The Growing geriatric population and increasing prevalence of chronic diseases along with favorable reimbursement for home healthcare equipment are key drivers for the U.S. market. The recent advancements in technology & cost-effectivity of home healthcare services are likely to drive growth during the forecast period.
The U.S. geriatric population has been growing rapidly over the past decade. As per the U.S. Census Bureau, 54 million adults in the U.S. are aged 65 years & above, accounting for 16.5% of the country’s population. The geriatric population typically prefers to stay at home as they age instead of a medical facility. Moreover, older patients opt for home healthcare services following surgery or treatment at the hospital to reduce the hospital stay, resulting in higher demand for home healthcare services. Administration of medications at home for chronic disorders offers benefits, such as faster recovery, better experience, fewer complications, and reduced cost, which is boosting the demand for homecare services in the U.S.
Medicare provides reimbursement for home health services such as intermittent skilled nursing care, care provided by a home health aide, and therapy under either Part A or Part B, depending on the circumstances. However, government organizations are taking measures to get service providers to focus more on the clinical characteristics of the patients, to eliminate the use of therapy service thresholds. For instance, a major change to the reimbursement system in decades is the Patient-Driven Groupings Model (PDGM) that was implemented in January 2020, which is reshaping the reimbursement of home healthcare services.
The initial phase of the pandemic witnessed complete shutdowns and movement restrictions leading to a shortage of medical equipment for use at homes as well as hospitals. Restrictions on healthcare services and fear of COVID-19 infection resulted in increased adoption of home health services across the nation, as it helped treat patients with professional support at home itself, avoiding the risk of infection. Healthcare facilities are providing care programs such as hospital-at-home and SNF-at-home that is reducing the stress on facilities and saving healthcare expenditure for patients. The U.S Government is undertaking initiatives to expand access to home healthcare.
The concept of home healthcare has evolved over the years and is likely to play an integral role in future healthcare systems in the U.S. Over the past few years, there have been rapid advancements in technologies used by home healthcare providers. Electronic visit verification is an upcoming technology, that facilitates verification of caregiver appointments, scheduling, & cancellation, avoiding no-show home appointments. The verification includes information about the patient and home healthcare professional, including the location, date, and time of service required. According to the social services department, by 2023, all home healthcare service providers in the U.S. must implement electronic visit verification, as per recent regulations.
The segment is categorized into equipment and services. The services segment held the largest market share in terms of revenue during 2023, especially due to the increasing adoption of long-term care services and recurring costs incurred by the patients as compared to the one-time purchase cost of equipment. The increasing focus of manufacturers on introducing innovative equipment, availability of reimbursement, and increasing at-home treatment/diagnostic efficiency are factors expected to contribute to the fastest growth of the equipment segment over the forecast period.
The services segment is broadly classified into skilled home healthcare services and unskilled home healthcare services. The skilled home healthcare services segment accounted for the largest share in terms of market revenue and is expected to register the fastest growth over the forecast period. Increasing home healthcare agencies, rising demand for home healthcare services, and favorable health reimbursement policies are major factors contributing to segment growth. Patients are choosing to recover at home instead of an inpatient facility due to greater comfort and reduced healthcare costs, which has led to a rise in demand for skilled medical care services in the market.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. home healthcare market
Component
Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.2 Estimates and Forecast Timeline
1.3 Objectives
1.3.1 Objective - 1
1.3.2 Objective - 2
1.3.3 Objective - 3
1.4 Research Methodology
1.5 Information Procurement
1.5.1 Purchased database:
1.5.2 Internal Database
1.5.3 Secondary sources
1.5.4 Primary research
1.6 Information or Data Analysis
1.7 Market Formulation & Validation
1.8 Model Details
1.8.1 Commodity Flow Analysis
1.9 List of Secondary Sources
1.10 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market & Segment Snapshot
2.2 Competitive Landscape
Chapter 3 U.S. Home Healthcare Service Market - Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market
3.1.2 Ancillary Market
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory Scenario & Reimbursement Framework
3.3.1 Regulatory Scenario
3.3.2 Reimbursement Framework
3.3.2.1 Public payers
3.3.2.2 Private payers
3.4 Technological Aids Used by Home Healthcare Providers
3.4.1 Scheduling Software
3.4.2 Remote Patient Monitoring
3.4.3 Telehealth
3.5 Impact of COVID 19
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.1.1 Growing geriatric population and increasing prevalence of chronic diseases
3.6.1.2 Favorable reimbursement for home healthcare equipment
3.6.1.3 Rapid technological advancement
3.6.1.4 Home healthcare as a cost-effective alternative
3.6.2 Market Restraint Analysis
3.6.2.1 Shortage of workforce
3.6.2.2 Complicated reimbursement framework and reimbursement cuts
3.6.2.3 Risks associated with home healthcare equipment
3.6.3 Supply Demand Analysis
3.6.4 Consumer Behavior Analysis
3.6.5 Industry Analysis - Porter’s Analysis
3.6.5.1 Competitive rivalry
3.6.5.2 Bargaining power of suppliers
3.6.5.3 Bargaining power of buyers
3.6.5.4 Threat of substitutes
3.6.5.5 Threat of new entrants
Chapter 4 U.S. Home Healthcare Market: Component Analysis
4.1 Component Movement Analysis & Market Share, 2024 & 2033
4.2 Component Segment Dashboard
4.2.1 Service
4.2.1.1 Service market, 2021 - 2033
4.2.1.2 Skilled care Services
4.2.1.2.1 Skilled care services market, 2021 - 2033
4.2.1.2.2 Nursing care
4.2.1.2.2.1 Nursing care market, 2021 - 2033
4.2.1.2.3 Physician/primary care
4.2.1.2.3.1 Physician/primary care market, 2021 - 2033
4.2.1.2.4 Hospice & palliative care
4.2.1.2.4.1 Hospice & palliative care market, 2021 - 2033
4.2.1.2.5 Physical/occupational/speech therapy
4.2.1.2.5.1 Physical/occupational/speech therapy market, 2021 - 2033
4.2.1.2.6 Nutritional Support
4.2.1.2.6.1 Nutritional support market, 2021 - 2033
4.2.1.2.7 Other skilled home healthcare services
4.2.1.2.7.1 Other skilled home healthcare market, 2021 - 2033
4.2.1.3 Unskilled Home Healthcare Services
4.2.1.3.1 Unskilled home healthcare market, 2021 - 2033
4.2.2 Equipment
4.2.2.1 Equipment market, 2021 - 2033
4.2.2.2 Therapeutic Equipment
4.2.2.2.1 Therapeutic equipment market, 2021 - 2033
4.2.2.2.2 Home respiratory equipment
4.2.2.2.2.1 Home respiratory market, 2021 - 2033
4.2.2.2.3 Home IV pumps
4.2.2.2.3.1 Home IV pumps market, 2021 - 2033
4.2.2.2.4 Home dialysis equipment
4.2.2.2.4.1 Home dialysis equipment market, 2021 - 2033
4.2.2.2.5 Insulin delivery
4.2.2.2.5.1 Insulin delivery market, 2021 - 2033
4.2.2.2.6 Other therapeutic equipment
4.2.2.2.6.1 Other therapeutic equipment market, 2021 - 2033
4.2.2.3 Diagnostic Equipment
4.2.2.3.1 Diagnostic equipment market, 2021 - 2033
4.2.2.3.2 Diabetic care unit
4.2.2.3.2.1 Diabetic care unit market, 2021 - 2033
4.2.2.3.3 BP monitors
4.2.2.3.3.1 BP monitors market, 2021 - 2033
4.2.2.3.4 Multi para diagnostic monitors
4.2.2.3.4.1 Multi para diagnostic market, 2021 - 2033
4.2.2.3.5 Apnea and sleep monitors
4.2.2.3.5.1 Apnea and sleep monitors market, 2021 - 2033
4.2.2.3.6 Home pregnancy and fertility kits
4.2.2.3.6.1 Home pregnancy and fertility kits market, 2021 - 2033
4.2.2.3.7 Holter monitors
4.2.2.3.7.1 Holter monitors market, 2021 - 2033
4.2.2.3.8 Heart rate meters
4.2.2.3.8.1 Heart rate monitors market, 2021 - 2033.
4.2.2.3.9 Other Diagnostic equipment
4.2.2.3.9.1 Other diagnostic equipment market, 2021 - 2033
4.2.2.4 Mobility Assist Equipment
4.2.2.4.1 Mobility assist equipment market, 2021 - 2033
4.2.2.4.2 Wheelchair
4.2.2.4.2.1 Wheelchair market, 2021 - 2033
4.2.2.4.3 Home Medical Furniture
4.2.2.4.3.1 Home medical furniture market, 2021 - 2033
4.2.2.4.4 Walking Assist Devices
4.2.2.4.4.1 Walking assist devices market, 2021 - 2033
Chapter 5 Competitive Landscape
5.1 Participant’s Overview
5.1.1 Manufacturers
5.1.2 Service Providers
5.2 Financial Performance
5.2.1 Manufacturers
5.2.2 Service Providers
5.3 Participant Categorization: Manufacturers
5.3.1 Strategy Mapping
5.3.1.1 Expansion
5.3.1.2 Acquisition
5.3.1.3 Collaborations
5.3.1.4 Product/Service Launch
5.3.1.5 Partnerships
5.3.1.6 Others
5.4 Product/Service Benchmarking
5.4.1 Equipment Manufacturers: Product Benchmarking
5.4.1.1 Extendicare, Inc.
5.4.1.2 Homecare pharmacy
5.4.1.3 McKesson Medical-Surgical, Inc.
5.4.1.4 NxStage Medical (Fresenius Medical Care)
5.4.1.5 Medline Industries Inc.
5.4.1.6 Medtronic plc
5.4.1.7 3M Healthcare
5.4.1.8 Baxter International Inc.
5.4.1.9 B. Braun Melsungen AG
5.4.1.10 Hoffman-La Roche AG
5.4.1.11 Becton, Dickinson and Company
5.4.2 Service Providers: Service Benchmarking
5.4.2.1 Atria Senior Living, Inc.
5.4.2.2 Amedisys, Inc.
5.4.2.3 Diversicare Healthcare Services, Inc.
5.4.2.4 Brookdale Senior Living Inc.
5.4.2.5 Kindred Healthcare, Inc.
5.4.2.6 Sunrise Senior Living, LLC
5.4.2.7 Genesis HealthCare
5.4.2.8 Sonida Senior Living. (Capital Senior Living CORPORATION)
5.4.2.9 Senior Care Center
5.4.2.10 Home Instead, Inc.
5.5 Vendor Landscape
5.5.1 List of Few Home Healthcare Providers
5.5.2 List of Few Home Healthcare Equipment Distributors in the U.S.
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers